XML 42 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Segment information (Tables)
 9 Months Ended
Sep. 25, 2022
Segment Reporting [Abstract]  
Segment Results
The following tables present our segment results for the three and nine months ended September 25, 2022 and September 26, 2021:
 Three Months EndedNine Months Ended
 September 25, 2022September 26, 2021September 25, 2022September 26, 2021
Americas$405,038 $417,330 $1,195,739 $1,207,608 
EMEA128,437 143,882 410,535 442,264 
Asia82,025 74,956 227,824 219,249 
OEM71,288 64,083 198,947 178,528 
Net revenues$686,788 $700,251 $2,033,045 $2,047,649 
Three Months EndedNine Months Ended
September 25, 2022September 26, 2021September 25, 2022September 26, 2021
Americas$107,180 $112,476 $318,548 $301,457 
EMEA7,472 19,566 29,291 65,862 
Asia22,885 27,536 61,796 65,640 
OEM18,438 14,359 47,197 42,183 
Total segment operating profit (1)
155,975 173,937 456,832 475,142 
Unallocated expenses (2)
(23,530)67,038 (85,694)(2,113)
Income from continuing operations before interest and taxes$132,445 $240,975 $371,138 $473,029 
(1)Segment operating profit includes segment net revenues from external customers reduced by its standard cost of goods sold, adjusted for fixed manufacturing cost absorption variances, selling, general and administrative expenses, research and development expenses and an allocation of corporate expenses. Commencing on January 1, 2022, all corporate expenses are allocated amongst the segments in proportion to the respective amounts of net revenues. The change in the measure of segment operating profit does not impact period over period comparability because the change was immaterial. For the three and nine months ended September 26, 2021, corporate expenses were allocated among the segments in proportion to the respective amounts of one of several items (such as sales, numbers of employees, and amount of time spent), depending on the category of expense involved.
(2)Unallocated expenses primarily include manufacturing variances other than fixed manufacturing cost absorption variances, restructuring and impairment charges and gain on sale of business.